Nifedipine in the prophylaxis of classic migraine: A crossover, double-masked, placebo-controlled study of headache frequency and side effects

J. C. McArthur; K. Marek; A. Pestronk; J. McArthur

doi:10.1212/wnl.39.2.284

Nifedipine in the prophylaxis of classic migraine: A crossover, double-masked, placebo-controlled study of headache frequency and side effects

J. C. McArthur, K. Marek, A. Pestronk, J. McArthur

School of Medicine

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Abstract

Twenty-four patients with classic migraine attacks were treated with either nifedipine or placebo for up to 12 weeks. No significant differences were observed between the nifedipine (2.1 ± 0.2) and placebo (2.3 ± 0.2) treatment groups in the monthly frequency of headaches. However, the incidence of side effects was significantly greater (p < 0.001) in the nifedipine (54% of patients) than in the placebo (8% of patients) treatment groups.

Original language	English (US)
Pages (from-to)	284-286
Number of pages	3
Journal	Neurology
Volume	39
Issue number	2
DOIs	https://doi.org/10.1212/wnl.39.2.284
State	Published - Feb 1989

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/wnl.39.2.284

Cite this

@article{d89607d33b194fb0af8da99ca17cabbb,

title = "Nifedipine in the prophylaxis of classic migraine: A crossover, double-masked, placebo-controlled study of headache frequency and side effects",

abstract = "Twenty-four patients with classic migraine attacks were treated with either nifedipine or placebo for up to 12 weeks. No significant differences were observed between the nifedipine (2.1 ± 0.2) and placebo (2.3 ± 0.2) treatment groups in the monthly frequency of headaches. However, the incidence of side effects was significantly greater (p < 0.001) in the nifedipine (54% of patients) than in the placebo (8% of patients) treatment groups.",

author = "McArthur, {J. C.} and K. Marek and A. Pestronk and J. McArthur",

year = "1989",

month = feb,

doi = "10.1212/wnl.39.2.284",

language = "English (US)",

volume = "39",

pages = "284--286",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Nifedipine in the prophylaxis of classic migraine

T2 - A crossover, double-masked, placebo-controlled study of headache frequency and side effects

AU - McArthur, J. C.

AU - Marek, K.

AU - Pestronk, A.

AU - McArthur, J.

PY - 1989/2

Y1 - 1989/2

N2 - Twenty-four patients with classic migraine attacks were treated with either nifedipine or placebo for up to 12 weeks. No significant differences were observed between the nifedipine (2.1 ± 0.2) and placebo (2.3 ± 0.2) treatment groups in the monthly frequency of headaches. However, the incidence of side effects was significantly greater (p < 0.001) in the nifedipine (54% of patients) than in the placebo (8% of patients) treatment groups.

AB - Twenty-four patients with classic migraine attacks were treated with either nifedipine or placebo for up to 12 weeks. No significant differences were observed between the nifedipine (2.1 ± 0.2) and placebo (2.3 ± 0.2) treatment groups in the monthly frequency of headaches. However, the incidence of side effects was significantly greater (p < 0.001) in the nifedipine (54% of patients) than in the placebo (8% of patients) treatment groups.

UR - http://www.scopus.com/inward/record.url?scp=0024535596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024535596&partnerID=8YFLogxK

U2 - 10.1212/wnl.39.2.284

DO - 10.1212/wnl.39.2.284

M3 - Article

C2 - 2644581

AN - SCOPUS:0024535596

SN - 0028-3878

VL - 39

SP - 284

EP - 286

JO - Neurology

JF - Neurology

IS - 2

ER -

Nifedipine in the prophylaxis of classic migraine: A crossover, double-masked, placebo-controlled study of headache frequency and side effects

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this